Evidence map›Paper›PMID 38299234›Full record

ArticleOncology reports2024

Evaluation of DNA methylation levels of

Ilaria Grossi, Claudia Assoni, Luigi Lorini, Davide Smussi, Cristina Gurizzan, Salvatore Grisanti, Alberto Paderno, Davide Mattavelli, Cesare Piazza, Iulia Andreea Pelisenco and 3 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Ilaria GrossiDivision of Biology and Genetics, Department of Molecular and Translational Medicine, University of Brescia, I‑25123 Brescia, Italy.
Claudia AssoniUnit of Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, ASST Spedali Civili of Brescia, University of Brescia, I‑25123 Brescia, Italy.
Luigi LoriniUnit of Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, ASST Spedali Civili of Brescia, University of Brescia, I‑25123 Brescia, Italy.
Davide SmussiUnit of Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, ASST Spedali Civili of Brescia, University of Brescia, I‑25123 Brescia, Italy.
Cristina GurizzanUnit of Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, ASST Spedali Civili of Brescia, University of Brescia, I‑25123 Brescia, Italy.
Salvatore GrisantiUnit of Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, ASST Spedali Civili of Brescia, University of Brescia, I‑25123 Brescia, Italy.
Alberto PadernoUnit of Otorhinolaryngology‑Head and Neck Surgery, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, ASST Spedali Civili of Brescia, University of Brescia, I‑25123 Brescia, Italy.
Davide MattavelliUnit of Otorhinolaryngology‑Head and Neck Surgery, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, ASST Spedali Civili of Brescia, University of Brescia, I‑25123 Brescia, Italy.
Cesare PiazzaUnit of Otorhinolaryngology‑Head and Neck Surgery, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, ASST Spedali Civili of Brescia, University of Brescia, I‑25123 Brescia, Italy.
Iulia Andreea PelisencoDivision of Biology and Genetics, Department of Molecular and Translational Medicine, University of Brescia, I‑25123 Brescia, Italy.
Giuseppina De PetroDivision of Biology and Genetics, Department of Molecular and Translational Medicine, University of Brescia, I‑25123 Brescia, Italy.
Alessandro SalviDivision of Biology and Genetics, Department of Molecular and Translational Medicine, University of Brescia, I‑25123 Brescia, Italy.
Paolo BossiUnit of Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, ASST Spedali Civili of Brescia, University of Brescia, I‑25123 Brescia, Italy.
University of Brescia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Head and neck squamous cell carcinoma (HNSCC) is the seventh most commonly diagnosed cancer globally. HNSCC develops from the mucosa of the oral cavity, pharynx and larynx. Methylation levels of septin 9 (

Indexed as

Carcinoma, Squamous CellCell-Free Nucleic AcidsHead and Neck NeoplasmsBiomarkers, TumorCytoskeletal ProteinsDNA MethylationGenes, HomeoboxHomeodomain ProteinsHumansPolymerase Chain ReactionSquamous Cell Carcinoma of Head and NeckBiomarkers, TumorCell-Free Nucleic AcidsCytoskeletal ProteinsHomeodomain ProteinsSHOX2 protein, humancell free DNADNA methylationdroplet digital PCRhead and neck squamous cell carcinomaliquid biopsy

Identifiers

PMID38299234
PMCPMC10865173
OpenAlexW4391386861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.